{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:18:25Z","timestamp":1793938705023,"version":"4.8.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A5A8029490"],"award-info":[{"award-number":["2021R1A5A8029490"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1A5A8029490"],"award-info":[{"award-number":["2021R1A5A8029490"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The cytoskeleton is a dynamic intracellular protein network composed of actin filaments, microtubules and intermediate filaments that provides structural support in cells and plays a crucial role in tumor metastasis. Tumor cells encounter various dynamic mechanical environments during metastasis, and they adapt to these environments through cytoskeletal reorganization, which enables them to regulate cell morphology, generate intracellular forces and induce intracellular signaling. Actin filaments contribute to migration and extracellular matrix degradation by forming protrusive structures, such as lamellipodia, filopodia and invadopodia. Microtubules support migration, stabilize cell polarity and enhance survival under shear stress. Intermediate filaments maintain structural integrity and mechanical flexibility, allowing cancer cells to pass through narrow spaces. The cytoskeleton\u2019s pivotal role in regulating metastasis makes it a promising drug target. However, cytoskeleton-targeting drugs often face the challenges of nonspecificity and drug resistance. Recent advancements in the field have tried to overcome these limitations through selective targeting, drug delivery systems, antibody\u2013drug conjugates and combination therapies. Here we summarize the roles and regulatory mechanisms of the cytoskeleton in metastasis and discusse the current cytoskeleton-targeting therapies, including their mechanisms, clinical applications and limitations. Furthermore, this review suggests future directions for developing effective and safe cytoskeleton-based interventions against metastasis.<\/jats:p>","DOI":"10.1038\/s12276-025-01608-9","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T01:59:50Z","timestamp":1767751190000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Roles of cytoskeleton in metastasis: from its mechanism to therapeutic strategies"],"prefix":"10.1038","volume":"58","author":[{"given":"Seyeon","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyeon","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5199-3415","authenticated-orcid":false,"given":"Kwang Dong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"1608_CR1","doi-asserted-by":"crossref","unstructured":"Fares, J., Fares, M. Y., Khachfe, H. H., Salhab, H. A. & Fares, Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal. Transduct. Target. Ther. 5, 28 (2020).","DOI":"10.1038\/s41392-020-0134-x"},{"key":"1608_CR2","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger, S., Jiang, Q. & Ganesh, K. Metastasis. Cell 186, 1564\u20131579 (2023).","journal-title":"Cell"},{"key":"1608_CR3","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1111\/bph.12704","volume":"171","author":"CM Fife","year":"2014","unstructured":"Fife, C. M., McCarroll, J. A. & Kavallaris, M. Movers and shakers: cell cytoskeleton in cancer metastasis. Br. J. Pharmacol. 171, 5507\u20135523 (2014).","journal-title":"Br. J. Pharmacol."},{"key":"1608_CR4","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.7150\/ijbs.44943","volume":"16","author":"X Li","year":"2020","unstructured":"Li, X. & Wang, J. Mechanical tumor microenvironment and transduction: cytoskeleton mediates cancer cell invasion and metastasis. Int. J. Biol. Sci. 16, 2014 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"1608_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.devcel.2020.10.011","volume":"56","author":"V Gensbittel","year":"2021","unstructured":"Gensbittel, V. et al. Mechanical adaptability of tumor cells in metastasis. Dev. Cell 56, 164\u2013179 (2021).","journal-title":"Dev. Cell"},{"key":"1608_CR6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","volume":"9","author":"X Shi","year":"2024","unstructured":"Shi, X. et al. Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives. Signal. Transduct. Target. Ther. 9, 192 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"1608_CR7","doi-asserted-by":"publisher","first-page":"a018267","DOI":"10.1101\/cshperspect.a018267","volume":"10","author":"T Svitkina","year":"2018","unstructured":"Svitkina, T. The actin cytoskeleton and actin-based motility. Cold Spring Harb. Perspect. Biol. 10, a018267 (2018).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1608_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0092-8674(03)00120-X","volume":"112","author":"TD Pollard","year":"2003","unstructured":"Pollard, T. D. & Borisy, G. G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112, 453\u2013465 (2003).","journal-title":"Cell"},{"key":"1608_CR9","doi-asserted-by":"publisher","first-page":"a018226","DOI":"10.1101\/cshperspect.a018226","volume":"8","author":"TD Pollard","year":"2016","unstructured":"Pollard, T. D. Actin and actin-binding proteins. Cold Spring Harb. Perspect. Biol. 8, a018226 (2016).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1608_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/biology9110385","volume":"9","author":"J Aseervatham","year":"2020","unstructured":"Aseervatham, J. Cytoskeletal remodeling in cancer. Biology 9, 385 (2020).","journal-title":"Biology"},{"key":"1608_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ceb.2016.04.005","volume":"42","author":"KF Swaney","year":"2016","unstructured":"Swaney, K. F. & Li, R. Function and regulation of the Arp2\/3 complex during cell migration in diverse environments. Curr. Opin. Cell Biol. 42, 63\u201372 (2016).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1608_CR12","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1126\/science.1163595","volume":"322","author":"CE Chan","year":"2008","unstructured":"Chan, C. E. & Odde, D. J. Traction dynamics of filopodia on compliant substrates. Science 322, 1687\u20131691 (2008).","journal-title":"Science"},{"key":"1608_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.bbamcr.2008.12.018","volume":"1803","author":"H Mellor","year":"2010","unstructured":"Mellor, H. The role of formins in filopodia formation. Biochim. Biophys. Acta Mol. Cell Res. 1803, 191\u2013200 (2010).","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"1608_CR14","first-page":"1855","volume":"125","author":"S Tojkander","year":"2012","unstructured":"Tojkander, S., Gateva, G. & Lappalainen, P. Actin stress fibers\u2014assembly, dynamics and biological roles. J. Cell Sci. 125, 1855\u20131864 (2012).","journal-title":"J. Cell Sci."},{"key":"1608_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1083\/jcb.200602085","volume":"175","author":"GT Charras","year":"2006","unstructured":"Charras, G. T., Hu, C.-K., Coughlin, M. & Mitchison, T. J. Reassembly of contractile actin cortex in cell blebs. J. Cell Biol. 175, 477\u2013490 (2006).","journal-title":"J. Cell Biol."},{"key":"1608_CR16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114994119","volume":"119","author":"BJ LaFrance","year":"2022","unstructured":"LaFrance, B. J. et al. Structural transitions in the GTP cap visualized by cryo-electron microscopy of catalytically inactive microtubules. Proc. Natl Acad. Sci. USA 119, e2114994119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1608_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/cells8040362","volume":"8","author":"T Hohmann","year":"2019","unstructured":"Hohmann, T. & Dehghani, F. The cytoskeleton-a complex interacting meshwork. Cells 8, 362 (2019).","journal-title":"Cells"},{"key":"1608_CR18","doi-asserted-by":"crossref","unstructured":"Goodson, H. V. & Jonasson, E. M. Microtubules and microtubule-associated proteins. Cold Spring Harb. Perspect. Biol. 10, a022608 (2018)..","DOI":"10.1101\/cshperspect.a022608"},{"key":"1608_CR19","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.tcb.2019.07.004","volume":"29","author":"S Bodakuntla","year":"2019","unstructured":"Bodakuntla, S., Jijumon, A., Villablanca, C., Gonzalez-Billault, C. & Janke, C. Microtubule-associated proteins: structuring the cytoskeleton. Trends Cell Biol. 29, 804\u2013819 (2019).","journal-title":"Trends Cell Biol."},{"key":"1608_CR20","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.3390\/ijms18102207","volume":"18","author":"D Wloga","year":"2017","unstructured":"Wloga, D., Joachimiak, E. & Fabczak, H. Tubulin post-translational modifications and microtubule dynamics. Int. J. Mol. Sci. 18, 2207 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"1608_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/bies.201500142","volume":"38","author":"A Robert","year":"2016","unstructured":"Robert, A., Hookway, C. & Gelfand, V. I. Intermediate filament dynamics: what we can see now and why it matters. Bioessays 38, 232\u2013243 (2016).","journal-title":"Bioessays"},{"key":"1608_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nrm3753","volume":"15","author":"NT Snider","year":"2014","unstructured":"Snider, N. T. & Omary, M. B. Post-translational modifications of intermediate filament proteins: mechanisms and functions. Nat. Rev. Mol. Cell Biol. 15, 163\u2013177 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1608_CR23","doi-asserted-by":"publisher","first-page":"102263","DOI":"10.1016\/j.ceb.2023.102263","volume":"85","author":"U R\u00f6lleke","year":"2023","unstructured":"R\u00f6lleke, U., Kumari, P., Meyer, R. & K\u00f6ster, S. The unique biomechanics of intermediate filaments\u2014from single filaments to cells and tissues. Curr. Opin. Cell Biol. 85, 102263 (2023).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1608_CR24","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1021\/acs.nanolett.2c00736","volume":"22","author":"K Pogoda","year":"2022","unstructured":"Pogoda, K. et al. Unique role of vimentin networks in compression stiffening of cells and protection of nuclei from compressive stress. Nano Lett. 22, 4725\u20134732 (2022).","journal-title":"Nano Lett."},{"key":"1608_CR25","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1021\/acsabm.1c01046","volume":"5","author":"M Swoger","year":"2022","unstructured":"Swoger, M. et al. Vimentin intermediate filaments mediate cell morphology on viscoelastic substrates. ACS Appl. Bio Mater. 5, 552\u2013561 (2022).","journal-title":"ACS Appl. Bio Mater."},{"key":"1608_CR26","doi-asserted-by":"publisher","first-page":"17145","DOI":"10.1074\/jbc.R115.640359","volume":"290","author":"J Lowery","year":"2015","unstructured":"Lowery, J., Kuczmarski, E. R., Herrmann, H. & Goldman, R. D. Intermediate filaments play a pivotal role in regulating cell architecture and function. J. Biol. Chem. 290, 17145\u201317153 (2015).","journal-title":"J. Biol. Chem."},{"key":"1608_CR27","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.3390\/cells10092246","volume":"10","author":"SM Perez","year":"2021","unstructured":"Perez, S. M., Brinton, L. T. & Kelly, K. A. Plectin in cancer: from biomarker to therapeutic target. Cells 10, 2246 (2021).","journal-title":"Cells"},{"key":"1608_CR28","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ejcb.2014.03.002","volume":"93","author":"M Sutoh Yoneyama","year":"2014","unstructured":"Sutoh Yoneyama, M. et al. Vimentin intermediate filament and plectin provide a scaffold for invadopodia, facilitating cancer cell invasion and extravasation for metastasis. Eur. J. Cell Biol. 93, 157\u2013169 (2014).","journal-title":"Eur. J. Cell Biol."},{"key":"1608_CR29","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1091\/mbc.E15-08-0552","volume":"26","author":"MH Lanier","year":"2015","unstructured":"Lanier, M. H., Kim, T. & Cooper, J. A. CARMIL2 is a novel molecular connection between vimentin and actin essential for cell migration and invadopodia formation. Mol. Biol. Cell 26, 4577\u20134588 (2015).","journal-title":"Mol. Biol. Cell"},{"key":"1608_CR30","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.cell.2005.09.021","volume":"123","author":"F Drees","year":"2005","unstructured":"Drees, F., Pokutta, S., Yamada, S., Nelson, W. J. & Weis, W. I. \u03b1-catenin is a molecular switch that binds E-cadherin-\u03b2-catenin and regulates actin-filament assembly. Cell 123, 903\u2013915 (2005).","journal-title":"Cell"},{"key":"1608_CR31","doi-asserted-by":"crossref","unstructured":"Zhitnyak, I.Y., Rubtsova, S.N., Litovka, N.I. & Gloushankova, N.A. Early events in actin cytoskeleton dynamics and E-cadherin-mediated cell-cell adhesion during epithelial\u2013mesenchymal transition. Cells 9, 578 (2020).","DOI":"10.3390\/cells9030578"},{"key":"1608_CR32","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.semcancer.2021.12.006","volume":"86","author":"NA Kuburich","year":"2022","unstructured":"Kuburich, N. A., den Hollander, P., Pietz, J. T. & Mani, S. A. Vimentin and cytokeratin: good alone, bad together. Semin. Cancer Biol. 86, 816\u2013826 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"1608_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13046-014-0062-0","volume":"33","author":"S Kaufhold","year":"2014","unstructured":"Kaufhold, S. & Bonavida, B. Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. J. Exp. Clin. Cancer Res. 33, 62 (2014).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"1608_CR34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41580-022-00530-6","volume":"24","author":"S Linder","year":"2023","unstructured":"Linder, S., Cervero, P., Eddy, R. & Condeelis, J. Mechanisms and roles of podosomes and invadopodia. Nat. Rev. Mol. Cell Biol. 24, 86\u2013106 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1608_CR35","doi-asserted-by":"crossref","unstructured":"Pratiwi, L., Elisa, E. & Sutanto, H. Probing the protrusions: lamellipodia and filopodia in cancer invasion and beyond. Mechanobiol. Med. 2, 100064 (2024).","DOI":"10.1016\/j.mbm.2024.100064"},{"key":"1608_CR36","first-page":"4","volume":"3","author":"A Jacob","year":"2015","unstructured":"Jacob, A. & Prekeris, R. The regulation of MMP targeting to invadopodia during cancer metastasis. Fronti. Cell Dev. Biol. 3, 4 (2015).","journal-title":"Fronti. Cell Dev. Biol."},{"key":"1608_CR37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.devcel.2016.11.009","volume":"39","author":"BP Bouchet","year":"2016","unstructured":"Bouchet, B. P. et al. Mesenchymal cell invasion requires cooperative regulation of persistent microtubule growth by SLAIN2 and CLASP1. Dev. Cell 39, 708\u2013723 (2016).","journal-title":"Dev. Cell"},{"key":"1608_CR38","doi-asserted-by":"crossref","unstructured":"Nazari, S.S., Doyle, A.D., Bleck, C.K.E. & Yamada, K.M. Long prehensile protrusions can facilitate cancer cell invasion through the basement membrane. Cells 12, 2474 (2023).","DOI":"10.3390\/cells12202474"},{"key":"1608_CR39","doi-asserted-by":"publisher","first-page":"1118171","DOI":"10.3389\/fonc.2023.1118171","volume":"13","author":"A Leg\u00e1tov\u00e1","year":"2023","unstructured":"Leg\u00e1tov\u00e1, A., Pelantov\u00e1, M., R\u00f6sel, D., Br\u00e1bek, J. & \u0160karkov\u00e1, A. The emerging role of microtubules in invasion plasticity. Front. Oncol. 13, 1118171 (2023).","journal-title":"Front. Oncol."},{"key":"1608_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.bcp.2015.11.005","volume":"99","author":"C Seidel","year":"2016","unstructured":"Seidel, C. et al. 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90\u03b1 chaperone activity against prostate cancer. Biochem. Pharmacol. 99, 31\u201352 (2016).","journal-title":"Biochem. Pharmacol."},{"key":"1608_CR41","doi-asserted-by":"publisher","first-page":"ar104","DOI":"10.1091\/mbc.E21-08-0414","volume":"33","author":"PC Marks","year":"2022","unstructured":"Marks, P. C., Hewitt, B. R., Baird, M. A., Wiche, G. & Petrie, R. J. Plectin linkages are mechanosensitive and required for the nuclear piston mechanism of three-dimensional cell migration. Mol. Biol. Cell 33, ar104 (2022).","journal-title":"Mol. Biol. Cell"},{"key":"1608_CR42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.bpj.2014.04.050","volume":"107","author":"M Mendez","year":"2014","unstructured":"Mendez, M., Restle, D. & Janmey, P. Vimentin enhances cell elastic behavior and protects against compressive stress. Biophys. J. 107, 314\u2013323 (2014).","journal-title":"Biophys. J."},{"key":"1608_CR43","doi-asserted-by":"publisher","first-page":"26756","DOI":"10.1073\/pnas.2011912117","volume":"117","author":"B Xuan","year":"2020","unstructured":"Xuan, B., Ghosh, D., Jiang, J., Shao, R. & Dawson, M. R. Vimentin filaments drive migratory persistence in polyploidal cancer cells. Proc. Natl Acad. Sci. USA 117, 26756\u201326765 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1608_CR44","doi-asserted-by":"crossref","unstructured":"Alexandrova, A. Y., Chikina, A. S. & Svitkina, T. M. Actin cytoskeleton in mesenchymal-to-amoeboid transition of cancer cells. Int. Rev. Cell Mol. Biol. 356, 197\u2013256 (2020).","DOI":"10.1016\/bs.ircmb.2020.06.002"},{"key":"1608_CR45","doi-asserted-by":"crossref","unstructured":"Alonso-Matilla, R., Provenzano, P. P. & Odde, D. J. Physical principles and mechanisms of cell migration. NPJ Biol. Phys. Mech. 2, 2 (2025).","DOI":"10.1038\/s44341-024-00008-w"},{"key":"1608_CR46","doi-asserted-by":"publisher","first-page":"1091801","DOI":"10.3389\/fcell.2022.1091801","volume":"10","author":"S George","year":"2022","unstructured":"George, S., Martin, J. A. J., Graziani, V. & Sanz-Moreno, V. Amoeboid migration in health and disease: Immune responses versus cancer dissemination. Front. Cell Dev. Biol. 10, 1091801 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"1608_CR47","doi-asserted-by":"crossref","unstructured":"Dimchev, G. et al. Lamellipodin tunes cell migration by stabilizing protrusions and promoting adhesion formation. J. Cell Sci. 133, jcs239020 (2020).","DOI":"10.1242\/jcs.239020"},{"key":"1608_CR48","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1038\/onc.2016.47","volume":"35","author":"G Carmona","year":"2016","unstructured":"Carmona, G. et al. Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena\/VASP and SCAR\/WAVE. Oncogene 35, 5155\u20135169 (2016).","journal-title":"Oncogene"},{"key":"1608_CR49","doi-asserted-by":"crossref","unstructured":"Jo, I., Sohn, K.-C., Kim, C. & Lee, Y. Effect of MITF-M and MITF-A overexpression on the dendrtic formation in melanocytes. Korean J. Phys. Anthropol. 29, 27-34 (2016).","DOI":"10.11637\/kjpa.2016.29.1.27"},{"key":"1608_CR50","doi-asserted-by":"publisher","first-page":"130001","DOI":"10.1098\/rsob.130001","volume":"3","author":"T Vallenius","year":"2013","unstructured":"Vallenius, T. Actin stress fibre subtypes in mesenchymal-migrating cells. Open Biol. 3, 130001 (2013).","journal-title":"Open Biol."},{"key":"1608_CR51","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1091\/mbc.E20-04-0270","volume":"31","author":"KW Cheng","year":"2020","unstructured":"Cheng, K. W. & Mullins, R. D. Initiation and disassembly of filopodia tip complexes containing VASP and lamellipodin. Mol. Biol. Cell 31, 2021\u20132034 (2020).","journal-title":"Mol. Biol. Cell"},{"key":"1608_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28961-x","volume":"13","author":"N Leijnse","year":"2022","unstructured":"Leijnse, N. et al. Filopodia rotate and coil by actively generating twist in their actin shaft. Nat. Commun. 13, 1636 (2022).","journal-title":"Nat. Commun."},{"key":"1608_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109716","volume":"36","author":"M Miihkinen","year":"2021","unstructured":"Miihkinen, M. et al. Myosin-X and talin modulate integrin activity at filopodia tips. Cell Rep. 36, 109716 (2021).","journal-title":"Cell Rep."},{"key":"1608_CR54","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10585-015-9775-5","volume":"33","author":"MJ Oudin","year":"2016","unstructured":"Oudin, M. J. et al. Characterization of the expression of the pro-metastatic MenaINV isoform during breast tumor progression. Clin. Exp. Metastasis 33, 249\u2013261 (2016).","journal-title":"Clin. Exp. Metastasis"},{"key":"1608_CR55","doi-asserted-by":"publisher","first-page":"ra112","DOI":"10.1126\/scisignal.2005329","volume":"7","author":"J Pignatelli","year":"2014","unstructured":"Pignatelli, J. et al. Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration. Sci. Signal. 7, ra112 (2014).","journal-title":"Sci. Signal."},{"key":"1608_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/srep36142","volume":"6","author":"MD Weidmann","year":"2016","unstructured":"Weidmann, M. D. et al. MenaINV dysregulates cortactin phosphorylation to promote invadopodium maturation. Sci. Rep. 6, 36142 (2016).","journal-title":"Sci. Rep."},{"key":"1608_CR57","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1083\/jcb.201501003","volume":"214","author":"CV Rajadurai","year":"2016","unstructured":"Rajadurai, C. V. et al. 5\u2032-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion. J. Cell Biol. 214, 719\u2013734 (2016).","journal-title":"J. Cell Biol."},{"key":"1608_CR58","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s12272-018-1051-1","volume":"41","author":"H Choi","year":"2018","unstructured":"Choi, H. & Moon, A. Crosstalk between cancer cells and endothelial cells: implications for tumor progression and intervention. Arch. Pharmacal Res. 41, 711\u2013724 (2018).","journal-title":"Arch. Pharmacal Res."},{"key":"1608_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43409-x","volume":"9","author":"E Gladilin","year":"2019","unstructured":"Gladilin, E. et al. TGF\u03b2-induced cytoskeletal remodeling mediates elevation of cell stiffness and invasiveness in NSCLC. Sci. Rep. 9, 7667 (2019).","journal-title":"Sci. Rep."},{"key":"1608_CR60","doi-asserted-by":"publisher","first-page":"3864","DOI":"10.1016\/j.celrep.2020.02.080","volume":"30","author":"DL Moose","year":"2020","unstructured":"Moose, D. L. et al. Cancer cells resist mechanical destruction in circulation via RhoA\/actomyosin-dependent mechano-adaptation. Cell Rep. 30, 3864\u20133874.e3866 (2020).","journal-title":"Cell Rep."},{"key":"1608_CR61","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1158\/0008-5472.CAN-14-2740","volume":"75","author":"JA McCarroll","year":"2015","unstructured":"McCarroll, J. A. et al. Tubb3\/\u03b2III-tubulin acts through the PTEN\/AKT signaling axis to promote tumorigenesis and anoikis resistance in non\u2013small cell lung cancer. Cancer Res. 75, 415\u2013425 (2015).","journal-title":"Cancer Res."},{"key":"1608_CR62","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1038\/onc.2010.68","volume":"29","author":"MA Matrone","year":"2010","unstructured":"Matrone, M. A. et al. Metastatic breast tumors express increased tau, which promotes microtentacle formation and the reattachment of detached breast tumor cells. Oncogene 29, 3217\u20133227 (2010).","journal-title":"Oncogene"},{"key":"1608_CR63","doi-asserted-by":"crossref","unstructured":"Xin, Y., Li, K., Yang, M. & Tan, Y. Fluid shear stress induces EMT of circulating tumor cells via JNK signaling in favor of their survival during hematogenous dissemination. Int. J. Mol. Sci. 21, 8115 (2020).","DOI":"10.3390\/ijms21218115"},{"key":"1608_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-024-01942-w","volume":"22","author":"J Jang","year":"2024","unstructured":"Jang, J., Park, H. J., Seong, W., Kim, J. & Kim, C. Vimentin-mediated buffering of internal integrin \u03b21 pool increases survival of cells from anoikis. BMC Biol. 22, 139 (2024).","journal-title":"BMC Biol."},{"key":"1608_CR65","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.7150\/ijbs.33423","volume":"15","author":"A Yamagishi","year":"2019","unstructured":"Yamagishi, A. et al. The structural function of nestin in cell body softening is correlated with cancer cell metastasis. Int. J. Biol. Sci. 15, 1546 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"1608_CR66","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1111\/cas.15146","volume":"112","author":"P Li","year":"2021","unstructured":"Li, P. et al. Notch-1 signaling promotes reattachment of suspended cancer cells by cdc42-dependent microtentacles formation. Cancer Sci. 112, 4894\u20134908 (2021).","journal-title":"Cancer Sci."},{"key":"1608_CR67","doi-asserted-by":"crossref","unstructured":"Ward, J. & Martin, P. Live-imaging studies reveal how microclots and the associated inflammatory response enhance cancer cell extravasation. J. Cell Sci. 136, jcs261225 (2023).","DOI":"10.1242\/jcs.261225"},{"key":"1608_CR68","doi-asserted-by":"crossref","unstructured":"Rodriguez-Hernandez, I., Cantelli, G., Bruce, F. & Sanz-Moreno, V. Rho, ROCK and actomyosin contractility in metastasis as drug targets. F1000Research 5, 783 (2016).","DOI":"10.12688\/f1000research.7909.1"},{"key":"1608_CR69","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.celrep.2014.07.050","volume":"8","author":"HS Leong","year":"2014","unstructured":"Leong, H. S. et al. Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis. Cell Rep. 8, 1558\u20131570 (2014).","journal-title":"Cell Rep."},{"key":"1608_CR70","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1083\/jcb.201312046","volume":"205","author":"BT Beaty","year":"2014","unstructured":"Beaty, B. T. et al. Talin regulates moesin\u2013NHE-1 recruitment to invadopodia and promotes mammary tumor metastasis. J. Cell Biol. 205, 737\u2013751 (2014).","journal-title":"J. Cell Biol."},{"key":"1608_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21345-7","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang, X., Liu, Y., Ding, Y. & Feng, G. CAMSAP2 promotes colorectal cancer cell migration and invasion through activation of JNK\/c-Jun\/MMP-1 signaling pathway. Sci. Rep. 12, 16899 (2022).","journal-title":"Sci. Rep."},{"key":"1608_CR72","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tranon.2018.09.006","volume":"12","author":"M Semelakova","year":"2019","unstructured":"Semelakova, M. et al. Vimentin and non-muscle myosin IIA are members of the neural precursor cell expressed developmentally down-regulated 9 (NEDD9) interactome in head and neck squamous cell carcinoma cells. Transl. Oncol. 12, 49\u201361 (2019).","journal-title":"Transl. Oncol."},{"key":"1608_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111319","volume":"406","author":"A Sherapura","year":"2025","unstructured":"Sherapura, A. et al. Withaferin-A induced vimentin S56 phosphorylation dissociates NEDD9 signaling loop to regress progressive metastatic melanoma into lung adenocarcinoma. Chem. Biol. Interact. 406, 111319 (2025).","journal-title":"Chem. Biol. Interact."},{"key":"1608_CR74","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/cancers12010238","volume":"12","author":"MS Ong","year":"2020","unstructured":"Ong, M. S. et al. Cytoskeletal proteins in cancer and intracellular stress: a therapeutic perspective. Cancers 12, 238 (2020).","journal-title":"Cancers"},{"key":"1608_CR75","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3892\/or.2013.2423","volume":"30","author":"F-Y Huang","year":"2013","unstructured":"Huang, F.-Y. et al. Cytochalasin D promotes pulmonary metastasis of B16 melanoma through expression of tissue factor. Oncol. Rep. 30, 478\u2013484 (2013).","journal-title":"Oncol. Rep."},{"key":"1608_CR76","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1469-7793.2000.00405.x","volume":"529","author":"S Calaghan","year":"2000","unstructured":"Calaghan, S., White, E., Bedut, S. & Le Guennec, J. Y. Cytochalasin D reduces Ca2+ sensitivity and maximum tension via interactions with myofilaments in skinned rat cardiac myocytes. J. Physiol. 529, 405\u2013411 (2000).","journal-title":"J. Physiol."},{"key":"1608_CR77","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1385\/JMN:28:2:151","volume":"28","author":"G Sierra-Paredes","year":"2006","unstructured":"Sierra-Paredes, G., Oreiro-Garc\u00eda, T., N\u00fa\u00f1ez-Rodriguez, A., V\u00e1zquez-L\u00f3pez, A. & Sierra-Marcu\u00f1o, G. Seizures induced by in vivo latrunculin a and jasplakinolide microperfusion in the rat hippocampus. J. Mol. Neurosci. 28, 151\u2013160 (2006).","journal-title":"J. Mol. Neurosci."},{"key":"1608_CR78","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s002800050850","volume":"42","author":"H Takeuchi","year":"1998","unstructured":"Takeuchi, H., Ara, G., Sausville, E. A. & Teicher, B. Jasplakinolide: interaction with radiation and hyperthermia in human prostate carcinoma and Lewis lung carcinoma. Cancer Chemother. Pharmacol. 42, 491\u2013496 (1998).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"1608_CR79","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.tiv.2012.12.005","volume":"27","author":"K Schweikart","year":"2013","unstructured":"Schweikart, K. et al. The effects of jaspamide on human cardiomyocyte function and cardiac ion channel activity. Toxicol. In Vitro 27, 745\u2013751 (2013).","journal-title":"Toxicol. In Vitro"},{"key":"1608_CR80","doi-asserted-by":"publisher","first-page":"e112542","DOI":"10.1371\/journal.pone.0112542","volume":"9","author":"MH Menhofer","year":"2014","unstructured":"Menhofer, M. H. et al. The actin targeting compound chondramide inhibits breast cancer metastasis via reduction of cellular contractility. PloS ONE 9, e112542 (2014).","journal-title":"PloS ONE"},{"key":"1608_CR81","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1093\/jnci\/90.20.1559","volume":"90","author":"F Sasse","year":"1998","unstructured":"Sasse, F., Kunze, B., Gronewold, T. M. & Reichenbach, H. The chondramides: cytostatic agents from myxobacteria acting on the actin cytoskeleton. J. Natl Cancer Insti. 90, 1559\u20131563 (1998).","journal-title":"J. Natl Cancer Insti."},{"key":"1608_CR82","doi-asserted-by":"publisher","first-page":"e1398","DOI":"10.1038\/cddis.2014.363","volume":"5","author":"F Foerster","year":"2014","unstructured":"Foerster, F. et al. Targeting the actin cytoskeleton: selective antitumor action via trapping PKC. Cell Death Dis. 5, e1398\u2013e1398 (2014).","journal-title":"Cell Death Dis."},{"key":"1608_CR83","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.trecan.2017.04.008","volume":"3","author":"A Gandalovi\u010dov\u00e1","year":"2017","unstructured":"Gandalovi\u010dov\u00e1, A. et al. Migrastatics\u2014anti-metastatic and anti-invasion drugs: promises and challenges. Trends Cancer 3, 391\u2013406 (2017).","journal-title":"Trends Cancer"},{"key":"1608_CR84","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.1158\/0008-5472.CAN-12-4501","volume":"73","author":"JR Stehn","year":"2013","unstructured":"Stehn, J. R. et al. A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells. Cancer Res. 73, 5169\u20135182 (2013).","journal-title":"Cancer Res."},{"key":"1608_CR85","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/IGC.0b013e3181c03909","volume":"19","author":"S Ogata","year":"2009","unstructured":"Ogata, S. et al. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells. Int. J. Gynecol. Cancer 19, 1473\u20131480 (2009).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"1608_CR86","doi-asserted-by":"publisher","first-page":"7526","DOI":"10.3892\/mmr.2015.4404","volume":"12","author":"L Jiang","year":"2015","unstructured":"Jiang, L., Wen, J. & Luo, W. Rho\u2011associated kinase inhibitor, Y\u201127632, inhibits the invasion and proliferation of T24 and 5367 bladder cancer cells. Mol. Med. Rep. 12, 7526\u20137530 (2015).","journal-title":"Mol. Med. Rep."},{"key":"1608_CR87","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1158\/0008-5472.CAN-14-2156","volume":"75","author":"A Sadok","year":"2015","unstructured":"Sadok, A. et al. Rho kinase inhibitors block melanoma cell migration and inhibit metastasis. Cancer Res. 75, 2272\u20132284 (2015).","journal-title":"Cancer Res."},{"key":"1608_CR88","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1158\/0008-5472.CAN-15-1864","volume":"76","author":"C Prunier","year":"2016","unstructured":"Prunier, C. et al. LIM kinase inhibitor Pyr1 reduces the growth and metastatic load of breast cancers. Cancer Res. 76, 3541\u20133552 (2016).","journal-title":"Cancer Res."},{"key":"1608_CR89","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.tcb.2018.05.001","volume":"28","author":"MO Steinmetz","year":"2018","unstructured":"Steinmetz, M. O. & Prota, A. E. Microtubule-targeting agents: strategies to hijack the cytoskeleton. Trends Cell Biol. 28, 776\u2013792 (2018).","journal-title":"Trends Cell Biol."},{"key":"1608_CR90","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s12094-011-0686-x","volume":"13","author":"J Gin\u00e9s","year":"2011","unstructured":"Gin\u00e9s, J. et al. Efficacy of taxanes as adjuvant treatment of breast cancer: a review and meta-analysis of randomised clinical trials. Clin. Transl. Oncol. 13, 485\u2013498 (2011).","journal-title":"Clin. Transl. Oncol."},{"key":"1608_CR91","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1021\/ja00738a045","volume":"93","author":"MC Wani","year":"1971","unstructured":"Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P. & McPhail, A. T. Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93, 2325\u20132327 (1971).","journal-title":"J. Am. Chem. Soc."},{"key":"1608_CR92","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1517\/14656566.3.12.1693","volume":"3","author":"S Ramalingam","year":"2002","unstructured":"Ramalingam, S. & Belani, C. P. Taxanes for advanced non-small cell lung cancer. Exp. Opin. Pharmacother. 3, 1693\u20131709 (2002).","journal-title":"Exp. Opin. Pharmacother."},{"key":"1608_CR93","doi-asserted-by":"publisher","first-page":"101959","DOI":"10.1016\/j.jddst.2020.101959","volume":"60","author":"M Imran","year":"2020","unstructured":"Imran, M., Saleem, S., Chaudhuri, A., Ali, J. & Baboota, S. Docetaxel: an update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer. J. Drug Deliv. Sci. Technol. 60, 101959 (2020).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"1608_CR94","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd3253","volume":"9","author":"C Dumontet","year":"2010","unstructured":"Dumontet, C. & Jordan, M. A. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat. Rev. Drug Discov. 9, 790\u2013803 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1608_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2020.151075","volume":"99","author":"V \u010cerm\u00e1k","year":"2020","unstructured":"\u010cerm\u00e1k, V. et al. Microtubule-targeting agents and their impact on cancer treatment. Eur. J. Cell Biol. 99, 151075 (2020).","journal-title":"Eur. J. Cell Biol."},{"key":"1608_CR96","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00280-019-03884-5","volume":"84","author":"ML Madsen","year":"2019","unstructured":"Madsen, M. L. et al. Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review. Cancer Chemother. Pharmacol. 84, 471\u2013485 (2019).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"1608_CR97","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1080\/14656566.2016.1217991","volume":"17","author":"C Gourmelon","year":"2016","unstructured":"Gourmelon, C. et al. Vinflunine for the treatment of breast cancer. Exp. Opin. Pharmacother. 17, 1817\u20131823 (2016).","journal-title":"Exp. Opin. Pharmacother."},{"key":"1608_CR98","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1007\/s13277-015-3072-4","volume":"36","author":"SN Hansen","year":"2015","unstructured":"Hansen, S. N. et al. Acquisition of docetaxel resistance in breast cancer cells reveals upregulation of ABCB1 expression as a key mediator of resistance accompanied by discrete upregulation of other specific genes and pathways. Tumor Biol. 36, 4327\u20134338 (2015).","journal-title":"Tumor Biol."},{"key":"1608_CR99","first-page":"440","volume":"37","author":"G Nightingale","year":"2012","unstructured":"Nightingale, G. & Ryu, J. Cabazitaxel (jevtana): a novel agent for metastatic castration-resistant prostate cancer. Pharm. Ther. 37, 440 (2012).","journal-title":"Pharm. Ther."},{"key":"1608_CR100","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/annonc\/mdn171","volume":"19","author":"X Pivot","year":"2008","unstructured":"Pivot, X. et al. A multicenter phase II study of XRP6258 administered as a 1-h IV infusion every 3 weeks in taxane-resistant metastatic breast cancer patients. Ann. Oncol. 19, 1547\u20131552 (2008).","journal-title":"Ann. Oncol."},{"key":"1608_CR101","first-page":"82","volume":"2","author":"W Krause","year":"2019","unstructured":"Krause, W. Resistance to anti-tubulin agents: from vinca alkaloids to epothilones. Cancer Drug Resist. 2, 82 (2019).","journal-title":"Cancer Drug Resist."},{"key":"1608_CR102","doi-asserted-by":"publisher","first-page":"617874","DOI":"10.3389\/fonc.2021.617874","volume":"11","author":"NK Ibrahim","year":"2021","unstructured":"Ibrahim, N. K. Ixabepilone: overview of effectiveness, safety, and tolerability in metastatic breast cancer. Front. Oncol. 11, 617874 (2021).","journal-title":"Front. Oncol."},{"key":"1608_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-018-1539-y","volume":"16","author":"S Wu","year":"2018","unstructured":"Wu, S., Du, Y., Beckford, J. & Alachkar, H. Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia. J. Transl. Med. 16, 1\u20139 (2018).","journal-title":"J. Transl. Med."},{"key":"1608_CR104","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10456-004-1026-3","volume":"7","author":"R Mohan","year":"2004","unstructured":"Mohan, R. et al. Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7, 115\u2013122 (2004).","journal-title":"Angiogenesis"},{"key":"1608_CR105","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.amjsurg.2012.07.027","volume":"204","author":"SM Cohen","year":"2012","unstructured":"Cohen, S. M., Mukerji, R., Timmermann, B. N., Samadi, A. K. & Cohen, M. S. A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers. Am. J. Surg. 204, 895\u2013901 (2012).","journal-title":"Am. J. Surg."},{"key":"1608_CR106","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/aps.2009.94","volume":"30","author":"K-j Wu","year":"2009","unstructured":"Wu, K. -j et al. Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression. Acta Pharmacol. Sin. 30, 1162\u20131168 (2009).","journal-title":"Acta Pharmacol. Sin."},{"key":"1608_CR107","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.3390\/ijms21134675","volume":"21","author":"I Ramos","year":"2020","unstructured":"Ramos, I., Stamatakis, K., Oeste, C. L. & P\u00e9rez-Sala, D. Vimentin as a multifaceted player and potential therapeutic target in viral infections. Int. J. Mol. Sci. 21, 4675 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1608_CR108","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.lungcan.2019.08.031","volume":"136","author":"Y-J Kim","year":"2019","unstructured":"Kim, Y.-J. et al. A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer. Lung Cancer 136, 122\u2013128 (2019).","journal-title":"Lung Cancer"},{"key":"1608_CR109","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1200\/JCO.2024.42.3_suppl.245","volume":"42","author":"C-H Hsu","year":"2024","unstructured":"Hsu, C.-H. et al. SKYSCRAPER-08: a phase III, randomized, double-blind, placebo-controlled study of first-line (1L) tiragolumab (tira)\u2009+\u2009atezolizumab (atezo) and chemotherapy (CT) in patients (pts) with esophageal squamous cell carcinoma (ESCC). J. Clin. Oncol. 42, 245\u2013245 (2024).","journal-title":"J. Clin. Oncol."},{"key":"1608_CR110","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41571-021-00496-y","volume":"18","author":"ZR Huinen","year":"2021","unstructured":"Huinen, Z. R., Huijbers, E. J. M., van Beijnum, J. R., Nowak-Sliwinska, P. & Griffioen, A. W. Anti-angiogenic agents\u2014overcoming tumour endothelial cell anergy and improving immunotherapy outcomes. Nat. Rev. Clin. Oncol. 18, 527\u2013540 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1608_CR111","doi-asserted-by":"crossref","unstructured":"Ricci, F., Guffanti, F., Damia, G. & Broggini, M. Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts. Mol. Cancer 16, 97 (2017).","DOI":"10.1186\/s12943-017-0662-3"},{"key":"1608_CR112","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1200\/JCO.2025.43.4_suppl.447","volume":"43","author":"K Sawada","year":"2025","unstructured":"Sawada, K. et al. Results of a phase 2 trial of ramucirumab plus docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903). J. Clin. Oncol. 43, 447\u2013447 (2025).","journal-title":"J. Clin. Oncol."},{"key":"1608_CR113","doi-asserted-by":"publisher","first-page":"450","DOI":"10.21037\/tlcr.2019.08.07","volume":"8","author":"A Yoshimura","year":"2019","unstructured":"Yoshimura, A. et al. Retrospective analysis of docetaxel in combination with ramucirumab for previously treated non-small cell lung cancer patients. Transl. Lung Cancer Res. 8, 450\u2013460 (2019).","journal-title":"Transl. Lung Cancer Res."},{"key":"1608_CR114","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1073\/pnas.1416418112","volume":"112","author":"MS Poruchynsky","year":"2015","unstructured":"Poruchynsky, M. S. et al. Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteins. Proc. Natl Acad. Sci. USA 112, 1571\u20131576 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1608_CR115","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.2147\/OTT.S109186","volume":"9","author":"EB Garon","year":"2016","unstructured":"Garon, E. B. et al. A randomized phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancer. OncoTargets Ther 9, 7275\u20137283 (2016).","journal-title":"OncoTargets Ther"},{"key":"1608_CR116","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ccell.2021.05.009","volume":"39","author":"L Pusztai","year":"2021","unstructured":"Pusztai, L. et al. Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II\/III breast cancer: results from the adaptively randomized I-SPY2 trial. Cancer Cell 39, 989\u2013998.e985 (2021).","journal-title":"Cancer Cell"},{"key":"1608_CR117","first-page":"207","volume":"8","author":"M Thomas","year":"2017","unstructured":"Thomas, M. et al. nab-paclitaxel\/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy. Lung Cancer 8, 207\u2013216 (2017).","journal-title":"Lung Cancer"},{"key":"1608_CR118","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jamaoncol.2020.2965","volume":"6","author":"KD Yu","year":"2020","unstructured":"Yu, K. D. et al. Effect of adjuvant paclitaxel and carboplatin on survival in women with triple-negative breast cancer: a phase 3 randomized clinical trial. JAMA Oncol. 6, 1390\u20131396 (2020).","journal-title":"JAMA Oncol."},{"key":"1608_CR119","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1021\/acsanm.2c05418","volume":"6","author":"C Oh","year":"2023","unstructured":"Oh, C. et al. Pulmonary surfactant-based paclitaxel-loaded nanovesicles for inhalation therapy of lung adenocarcinoma. ACS Appl. Nano Mater. 6, 3693\u20133703 (2023).","journal-title":"ACS Appl. Nano Mater."},{"key":"1608_CR120","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-11860-3","volume":"24","author":"R Li","year":"2024","unstructured":"Li, R. et al. Paclitaxel liposome (Lipusu) based chemotherapy combined with immunotherapy for advanced non-small cell lung cancer: a multicenter, retrospective real-world study. BMC Cancer 24, 107 (2024).","journal-title":"BMC Cancer"},{"key":"1608_CR121","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/cac2.12225","volume":"42","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. Paclitaxel liposome for injection (Lipusu) plus cisplatin versus gemcitabine plus cisplatin in the first-line treatment of locally advanced or metastatic lung squamous cell carcinoma: a multicenter, randomized, open-label, parallel controlled clinical study. Cancer Commun. 42, 3\u201316 (2022).","journal-title":"Cancer Commun."},{"key":"1608_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121395","volume":"613","author":"S Mojarad-Jabali","year":"2022","unstructured":"Mojarad-Jabali, S. et al. Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy. Int. J. Pharm. 613, 121395 (2022).","journal-title":"Int. J. Pharm."},{"key":"1608_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71129-0","volume":"10","author":"SM Jusu","year":"2020","unstructured":"Jusu, S. M. et al. Drug-encapsulated blend of PLGA\u2013PEG microspheres: in vitro and in vivo study of the effects of localized\/targeted drug delivery on the treatment of triple-negative breast cancer. Sci. Rep. 10, 14188 (2020).","journal-title":"Sci. Rep."},{"key":"1608_CR124","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.nano.2014.09.006","volume":"11","author":"NK Jain","year":"2015","unstructured":"Jain, N. K., Tare, M. S., Mishra, V. & Tripathi, P. K. The development, characterization and in vivo anti-ovarian cancer activity of poly(propylene imine) (PPI)-antibody conjugates containing encapsulated paclitaxel. Nanomedicine 11, 207\u2013218 (2015).","journal-title":"Nanomedicine"},{"key":"1608_CR125","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1158\/1078-0432.CCR-14-0012","volume":"20","author":"L Amiri-Kordestani","year":"2014","unstructured":"Amiri-Kordestani, L. et al. FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancer. Clin. Cancer Res. 20, 4436\u20134441 (2014).","journal-title":"Clin. Cancer Res."},{"key":"1608_CR126","first-page":"18","volume":"5","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Novel development strategies and challenges for anti-Her2 antibody\u2013drug conjugates. Antib. Ther. 5, 18\u201329 (2022).","journal-title":"Antib. Ther."},{"key":"1608_CR127","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s40265-021-01614-x","volume":"81","author":"ED Deeks","year":"2021","unstructured":"Deeks, E. D. Disitamab vedotin: first approval. Drugs 81, 1929\u20131935 (2021).","journal-title":"Drugs"}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01608-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01608-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01608-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:10:42Z","timestamp":1774419042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01608-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01608-9","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}